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VENTRICULAR MORPHOLOGY AND OUTCOME
Whilst the perception is that a single morphological left ventricle will have a better prognosis than a single right ventricle, other anatomical considerations play a greater role in the long term outcomes of patients with a univentricular circulation. The approach to Fontan palliation for patients with tricuspid atresia or double inlet right or left ventricle is largely similar with a staged approach culminating in a total cavopulmonary connection. However isomeric hearts will have abnormalities of pulmonary and systemic venous returns that require special consideration. Similarly the hypoplastic left ventricle will require complex immediate palliation in the neonatal period which is associated with a high early mortality.
These factors pass into adult life and palliated patients with isomeric circulations and hypoplastic left heart syndrome will have greater degrees of effort intolerance, a greater arrhythmia burden and will be more difficult to manage owing to the complexities of their condition.
SURVIVAL BEFORE FONTAN PALLIATION
The case for the Fontan circulation is easily made when considering survival statistics for patients with a univentricular circulation. The vast majority of patients with an unpalliated single left ventricular circulation will die before reaching adult life and survival is even worse with a single right ventricular circulation with survival above 5 years unlikely and worse still with the hypoplastic left heart syndrome (HLHS) where unoperated survival beyond one week is rare. Therefore the case for surgery to improve survival is easily made, and the Fontan operation in its various forms does deliver survival benefit, with survival to adult life to be expected in even the most complex forms of a univentricular heart. However, the Fontan circulation comes at a cost, with significant morbidity in childhood and increasing into adult life. There are also limitations to cardiopulmonary performance which are inherent in the Fontan circulation and will be discussed in detail below.
FONTAN ORIGINAL PAPER
In 1971, Francis Fontan published the first surgical paper outlining a palliative surgical procedure for patients with tricuspid atresia. (1) The paper describes in detail the formation of a valved conduit placed between the right atrium and the main pulmonary artery (MPA) with the formation of a classical Glenn connection between the superior vena cava (SVC) and the right pulmonary artery (RPA).
It became apparent early on that the valved conduit placed an unacceptably high resistance to pulmonary blood flow and this pro-
A B C FIGURE 1: Anatomical variations on a univentricular circulation.
A: Double inlet left ventricle with VA discordance and no pulmonary stenosis.
B: Tricuspid atresia with hypoplastic RV, VA concordance and hypoplastic pulmonary artery.
C: Hypoplastic left heart syndrome with AV and VA concordance, hypoplastic left ventricle, aorta and aortic arch.
cedure was altered to allow a direct connection of the right atrium to the main pulmonary artery, initially in combination with a classical Glenn operation, subsequently the connection was widened to allow flow into both pulmonary arteries and the SVC remained connected to the RA. This operation became the standard Fontan operation for many years and is referred to as a modified Fontan or an atriopulmonary (AP) Fontan operation.
(2) 
FONTAN'S TEN COMMANDMENTS

MODIFICATIONS TO THE FONTAN CIRCULATION
Whilst the AP Fontan was successful in providing long term survival and reduction in cyanosis, it is an inherently an inefficient circulation.
The RA dilates with time and becomes a capacitance chamber into which the SVC and IVC flow return, the forward flow into the lungs becomes turbulent and of low velocity and becomes more dependent with time on inspiration and diastolic relaxation of the ventricle for transpulmonary blood flow. This is due to the reducing effect of atrial contraction as the RA dilates.
The fundamentals of fluid mechanics need to be understood at this point: in a closed circuit turbulent flow leads to energy loss and an increase in power requirements. As the RA dilates with age the circulation becomes more inefficient and this places a greater stress on the single ventricle. Furthermore, in normal biventricular circulations, the pulmonary and systemic circulations are synchronised and each have a pump to work against the resistances. In the palliated univentricular circulation, the systemic circulation is pulsatile and the pulmonary circulation is not, the circulations run in series and the non-pulsatile pulmonary circulation causes a large reflective wave of resistance leading to an increased afterload. (6) In order to overcome this afterload the single ventricle hypertrophies.
The hypertrophied ventricle requires an increased pre-load to maintain the cardiac output and yet the Fontan patient has no means of increasing trans-pulmonary blood flow, beyond a modest increase in heart rate and an increase in respiratory rate.
DEVELOPMENT OF THE TOTAL CAVOPULMONARY CONNECTION (TCPC)
In order to address the issues of inefficiency in the Fontan circuit, Marc de Leval and colleagues developed the concept of a total cavopulmonary connection. (7) Using computational mathematical modeling techniques they demonstrated that by surgical creation of a tube to connect the IVC directly to the PA and by using a bidirectional Glenn, they could reduce power losses in the circuit and eventually by angling the connection of the IVC tunnel away from the SVC flow into the PA they optimised efficiency and minimised power losses. This tunnel can be achieved by two methods, which are routinely used in congenital surgical practice today: the lateral tunnel, created by the septation of the right atrium by means of a GoreTex patch (8) or by an extracardiac GoreTex tube, connecting the IVC to the PA. (9) This type of Fontan is often referred to as a "total cavopulmonary connection" or TCPC- 
HAEMODYNAMIC CONSEQUENCES OF FONTAN
CIRCULATION
The Fontan circulation in all its forms raises a challenge to our fundamental understanding of the circulation. Marc de Leval, discusses this at length in his review of 2005. (14) In short, the Fontan circulation is an alternative physiology to that described by Harvey and the long term management of the Fontan patient is dependent on a full understanding of this physiology. The cardiac output is dependent on adequate pre-load of the single ventricle, which in itself is dependent on a low pulmonary vascular resistance, maintenance of sinus rhythm and systemic venous hypertension. This is demonstrated in Figure 5 , where pressure in the various stages of the circulation is shown in the resting state and on exercise in a normal subject and in a Fontan patient. (15) In a normal subject cardiac output is increased by pre-load recruitment with the effect of the muscular venous pump, being to increase RV pre-load, and increased heart rate and force of contraction pushing blood through the pulmonary vascular bed, leading to increased pre-load to the left ventricle and a consequent increase in stroke volume, which coupled with increased heart rate leads to an increase in cardiac output. In comparison, the lack of a sub-pulmonary pump and preexistent systemic venous hypertension, a requirement of the Fontan circulation, means that during exercise there is little pre-load
A B C FIGURE 2: The Fontan operation and its modifi cations.
A: Modified atriopulmonary Fontan with direct connection between the right atrium and pulmonary artery.
B: Lateral Tunnel Fontan, a type of total cavopulmonary connection Fontan, with septation of the atrium by a GoreTex patch to connect the IVC to the PA with a bidirectional Glenn.
C: An extracardiac Fontan, a type of total cavopulmonary connection Fontan, with a GoreTex tube connecting the IVC to the PA.
recruitment and increases in cardiac output are determined by heart rate, but within a narrow range, as diastolic filling time becomes increasingly important to maintenance of pre-load . Thus, the Fontan patient is unable to increase cardiac output to the extent that a biventricular circulation can ( Figure 5 ). (16) There is therefore a built in limitation and fragility to the Fontan physiology, which becomes important when considering the late complications that patients may face.
EXERCISE LIMITATION
Objective cardiopulmonary exercise testing is limited in the Fontan patient, when even the "asymptomatic" Fontan patient will have a reduction in the measured peak VO 2 , typically in our experience around 70% of the predicted value and this is consistent across the different ventricular morphologies and anatomies, except the HLHS patients who on average have a lower peak VO 2 (62% of predicted).
Further studies in adult Fontan patients are required to determine which groups, if any, have an adverse outcome with regards to exercise performance.
FOLLOW UP OF ADULT FONTAN PATIENTS
Our standard approach to managing any adult with complex congenital heart disease starts in the teenage years, through the process 
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Volume 10 • Number 4 of transition. There is no absolute age at which transitional care starts, it clearly depends on individual patients' circumstances, although we aim to have started the process by the age of 14 if possible. Our approach is for a specialist transitional care nurse to meet with the patient and family in the paediatric clinic and start to develop a relationship. We discuss the diagnosis and the operations they have undergone and what impact, if any, this has had on them as individuals. We start the discussion regarding pregnancy and contraception whilst also counseling the patient against the use of recreational drugs and cigarette smoking. We discuss alcohol consumption and other lifestyle issues such as piercing and tattoos and the need for regular dental follow up. This is a process that occurs over a number of clinic visits and culminates in their transfer to adult services between the ages of 16 and 18 years.
Advice is also given regarding career options. Currently the UK armed forces will not accept recruits with any history of congenital heart disease. We also discuss appropriate sporting and other leisure activities, including whether they can scuba dive.
At their first visit we cover the same points raised in transition clinics, perform a routine cardiovascular examination and the following routine examinations: 12 Lead ECG, transthoracic echocardiogram, 24 hour ECG monitoring, cardiopulmonary exercise and cardiac MRI imaging in those in whom it is possible. This provides us with our baseline haemodynamic assessment, which we will compare future results with.
It is our standard practice to provide patients with a laminated copy of their 12 ECG for them to have with them in case they are ever reviewed in an emergency department with palpitations. Patients are also copied in to all correspondence so they have their own health care records. All patients are given contact details for the unit, the hospital and our clinical nurse specialists. Follow up is every 12 months or at short notice if a situation arises.
Medications
The non-pulsatile and often turbulent blood flow through the Fontan, predisposes the patient to thromboembolism, (17) (20, 21) and although no reports demonstrate superiority, (22) it is clear that either is necessary and without antiplatelet or anticoagulant therapy thromboembolic events are frequent. 
] In the normal circulation exercise leads to a rise in aortic pressure and a modest rise in systemic venous pressure (S), RV pressure increases as does PA pressure leading to an increase in pulmonary venous pressure (P) and an increase in pre-load to the LV. In the Fontan circulation S is already high and must remain higher than P to allow transpulmonary blood fl ow and the result is that on exercise there is little if any augmentation of ventricular preload.
A B
Normal subject Fontan patient Many of our patients are transitioned on ACE inhibitors and whilst there is little evidence base to support their use, (24, 25) we feel that there is no need to stop ACE inhibition and this is continued, often with a dose adjustment to adult dosage.
Imaging modalities used in adult congenital heart patients (26, 27) exclude obstruction and look at pulmonary venous return. (28, 29) In the HLHS post Norwood, it is the modality of choice for examining the Damus connection and the reconstructed aortic arch. It is time consuming and patients often find the magnetic claustrophobic and therefore cardiac MRI is not possible for all. It is also not possible to image patients with permanent pacemakers in the magnet. We have recently used gated cardiac CT in some individuals although our experience in this modality is insufficient to allow its true role to be established.
Cardiac catheterisation is used less in adults than in children, and again often requires a GA. However it does yield a wealth of information, both functional and pressure data and indirect estimates of cardiac output by measurement of the mixed venous saturation. Great care must be taken to ensure accurate zeroing of the pressure tracings as gradients as little as 1-2mmHg may be significant in these patients. We also use cardiac catheterisation to guide our interventions, often with TOE guidance. In adults catheter based interventions are not common, but may include stenting of branch pulmonary artery stenosis or venous pathway obstruction. (30) Coil or vascular plug embolisation of collaterals may be necessary in the profoundly cyanosed and also in patients with aortobronchial fistula, presenting with haemoptysis.
(31-33)
Assessment of exercise performance
Exercise testing is carried out at transition for nearly all ACHD patients. Whilst we previously used a standard Bruce protocol, this has proven to be a poor tool for discriminating who is limited. We now use cardiopulmonary exercise testing as a routine and the ability to demonstrate when a maximal test has been performed is key. The test will discriminate between respiratory, cardiac or neuromuscular causes of exercise limitation and can be used to guide the timing of and assessing the efficacy of an intervention.
We prefer to use in the able bodied a RAMP protocol on a standard treadmill, with continuous assessment of gas exchange. We routinely record the peak oxygen consumption (pVO 2 ), the respiratory exchange ratio (RER), the oxygen pulse, the anaerobic threshold (AT) and the VE/VCO 2 slope. These can then be tracked in subsequent tests to assess for deterioration.
Typically a Fontan patient will manage a pVO 2 around 60-70% of predicted values, (24) indicating a severe level of limitation and yet many may express little if any limitations to activities. Whilst the reasons for this are complex, Fontan patients in childhood are often advised to limit their activities and yet there is evidence for the benefits of exercise for Fontan patients. (35, 36) Holter monitoring 
LONG TERM COMPLICATIONS OF THE FONTAN
CIRCULATION
Atrial Arrhythmias
A frequent and life threatening complication is the occurrence of sustained atrial arrhythmias. (40, 41) The prompt recognition of the abnormal rhythm allows for rapid management of the arrhythmia which can be life saving. Our experience is that we are often called by an emergency room physician who is seeing a Fontan patient who reports an arrhythmia but who is in a normal rhythm.
Typically the arrhythmia takes the form of a macro re-entry scar Following successful cardioversion in a Fontan patient or any other complex congenital heart lesion, our current strategy is to offer electrophysiology studies (EPS) with a view to performing radio-frequency ablation of the scar related flutter circuit. The advent of 3D mapping systems has aided the management of these complex arrhythmias. (42) Our standard medical therapy is beta-blockade with a cardio-selective agent, typically bisoprolol.
Some advocate the use of sotalol owing to its additional class 3 activity. (43) We reserve amiodarone for recurrent atrial arrhythmias or sustained ventricular arrhythmias. The prolonged use of amiodarone has a high risk of thyroid dysfunction (43, 44) and photosensitivity reactions can be a major problem.
Whether an elective EP study for all adult Fontan patients is justified remains to be determined, but this may be warranted, especially given the association of arrhythmias and mortality in these patients. (45, 46) There will be difficulties encountered in EPS in patients with an extra-cardiac conduit Fontan, as there is no direct connection between the venous system and the atrial mass, however there are potential strategies.
Thromboembolism
The Fontan circuit by virtue of the low flow at rest and the lack of a sub-pulmonary ventricle is prone to thromboembolic phenomena. The abnormalities in clotting factors occur due to the Fontan circuit formation (48) (49) (50) and although the incidence of thromboembolism is lower in TCPC Fontan patients, (21) it can nevertheless occur (51) and we advocate anticoagulation with warfarin for all Fontan patients regardless of type.
Thrombus may present with evidence of pathway obstruction, such as ascites and the onset of protein losing enteropathy associated with effort tolerance and must be actively excluded. We use CT and MRI to look for patency of the Fontan pathway and the pulmonary arteries. Once demonstrated the management is difficult, routine anticoagulation with low molecular weight heparin and oral anticoagulation for those not routinely anticoagulated may be sufficient. Case reports have described successful outcomes with catheter delivered thrombolysis (52) and even surgical embolectomy (53, 54) and Fontan conversion surgery, (55, 56) however, a large occlusive thrombus is frequently fatal, regardless of management strategy. (53, 57) connection. (58, 59) These narrowed parts of the Fontan circuit would typically be addressed in the catheter laboratory with balloon dilatation or stent implantation in the older child and adult. (30, (60) (61) (62) Pulmonary venous pathway obstruction
One of the unwanted effects of the modified atriopulmonary
Fontan operation was dilatation of the right atrium, such that the right sided pulmonary veins became compressed. (63) This leads to an increase in the pulmonary vascular resistance and is associated with Fontan failure and is an indication for Fontan conversion surgery (55, 64) to a total cavopulmonary connection where compression of the veins is less likely.
Sub-aortic obstruction
The presence sub-aortic stenosis in the univentricular heart used to present the surgeon with great difficulty and any operation was associated with a high mortality (65) until the adaptation of the Norwood 1 operation for use in this particular anatomy. (66) Whilst the Damus operation has evolved as the treatment of choice for patients presenting with sub-aortic stenosis, there remains a small proportion of patients for whom this is a late complication following Fontan surgery. (67) (68) (69) (70) Surgery remains the standard management for this complication and can take the form of a sub-aortic resection (71) or late formation of a Damus connection. (72, 73) However, this comes at a cost of significant operative mortality. (71) High risk patients include those with univentricular hearts and transposition of the great vessels. (74, 75) In our experience patients have presented with effort intolerance and anginal symptoms but also asymptomatic with a progressive severe sub-aortic muscular obstruction. It remains a risk in many of the patients who have undergone a Fontan operation, and should be looked for during routine TTE.
Systemic atrioventricular valve regurgitation (AVVR)
The mechanism of AVVR in patients with a univentricular circulation remains poorly understood. It occurs in the non-palliated univentricular circulation (76, 77) and may be addressed at the time of Fontan completion. (78, 79) The development of AVVR post Fontan surgery is associated with morbidity and mortality (80) (81) (82) and surgery to repair the regurgitant valve is also associated with significant early and late mortality (83) however, if successful also leads to improvements in ventricular function. (84) 
Ventricular Dysfunction
The single ventricle pre-Fontan surgery is a chronically volume loaded chamber which undergoes adverse geometric changes if left volume loaded. (85) The Fontan operation leads to early improvements in ventricular function and hypertrophy. (86) (87) (88) By adult life the gains in ventricular function are largely lost with around a third of reported patients having moderate or severe ventricular function. (89) There are many plausible theories as to why late ventricular function occurs, with increasing systemic vascular resistance, due to abnormal vascular tone, (90) endothelial dysfunction, (91) (92) (93) and the abnormal resistances encountered by the pulmonary and systemic circulations running in series (6) all probably playing a part. The onset of significant valvular incompetence and the onset of atrial arrhythmias are both poorly tolerated.
Whilst there is a lack of evidence base for the use of conventional heart failure treatment, nevertheless there is little else to offer. Spironolactone may improve endothelial function (93) and carvedilol appears to improve systemic ventricular function (94) in Fontan patients, yet the role of ACE inhibitors remains unproven (24) despite their routine use alongside empirical use of diuretics.
Protein-losing enteropathy (PLE)
PLE is a devastating late complication of the Fontan operation. (95) It is associated with chronic protein loss from the gastrointestinal tract (96) and the presence of elevated fecal alpha-1 antitrypsin levels in association with a low serum albumin and generalised oedema is characteristic. (97, 98) The exact cause remains uncertain but chronic elevation of systemic venous pressures, lymphatic dysfunction, (99, 100) ventricular dysfunction, (101, 102) abnormal pulmonary vascular compliance (103) and intestinal heparan loss (104) have all been implicated. Pathway obstruction must be actively looked for and treated (98, 102, 105) and there are reports of PLE resolution by conversion to a TCPC Fontan (64, 106, 107) and by cardiac transplantation, (108, 109) however, both are technically challenging even without the presence of PLE and are associated with significant procedural mortality.
Many possible therapies have been suggested and these are directed symptomatic relief with diuretics (110) and dietary modifications, (111, 112) reduction in intestinal protein loss with the use of steroids (113) (114) (115) (116) and heparin (117) (118) (119) (120) (121) (122) (123) and improving the haemodynamics as described above.
Cyanosis
A degree of cyanosis is common in most adult Fontan patients, in many due to a fenestration made at the time of Fontan completion in order to maintain cardiac output in the early post operative period with an associated reduction in morbidity and mortality. (10, 124) Later percutaneous closure of the fenestration is often performed if cyanosis is profound and may be complete occlusion (125) (126) (127) or partial. (128, 129) Similarly, baffle leaks in the suture line of the fontan circuit, may lead to cyanosis which may be closed percutaneously. (130) Venous collaterals are also common and may be addressed in the catheter lab. (131, 132) Extra cardiac causes can occur and in some patients a severe restrictive lung defect may also occur, further impairing gas exchange.
Cyanosis is a multi-system disorder, typically the patient may have impaired clotting, with low platelet counts and abnormal clotting factors. They are at risk of acute renal injury and every effort must be made to keep the patient well hydrated and avoidance of nephrotoxic agents is advised. As with all cyanotic cardiac patients,
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Bradyarrhythmias
Whilst bradyarrhythmias are not typical post Fontan surgery, they are difficult to manage. Endovascular pacing of the single ventricle is often not possible without a "transeptal puncture" and a systemic ventricular pacing lead is not considered ideal due to the risk of thromboembolic complications. In those with pure sinus node dysfunction endovascular atrial pacing is a good option. (132, 133) The majority of ventricular pacing is epicardial. (134, 135) This requires at best a limited thorocotomy and may require full sternotomy and cardiopulmonary bypass, with the associated risks. In some patients access to the coronary sinus is possible via the Fontan circuit and in these "LV" leads have been placed with some success. (136) (137) (138) (139) Lead failure is not uncommon and again this is difficult to manage. (134, 140) Many centres will place epicardial pacing leads if a patient is undergoing conversion from an atriopulmonary to a TCPC Fontan as the risk of bradyarrhythmias is higher following the arrhythmia surgery typically performed during this operation. (141, 142) 
Hepatocellular carcinoma
Chronic elevation of the hepatic venous pressure is thought to lead to chronic liver pathology and there are a number of reported cases of hepatocellular carcinoma occurring late after Fontan surgery. (143) (144) (145) Screening for hepatic adenomas by annual liver imaging and alpha-feto protein levels has been recommended and is a low cost way of identifying these cases early in their disease course. (146) (147) (148) 
Prognosis
It is clear that the management of the univentricular circulation is a success story if considered in terms of survival benefit. Inevitable death in childhood has been turned into likely survival to adult life for the majority, yet it comes at a cost. The burden of impaired effort tolerance, the risk of arrhythmias and the likely decline into a low cardiac output state, whilst still a young adult, is considerable.
We do not know what the long term prognosis is for these patients. In the largest and longest follow up series published, a third of patients had died following a mean follow up period of 12 years. Yet the majority of these deaths were peri-operative and in survivors, 20 year survival rates were 82%. (19) It is possible that surgical modifications will lead to improvements in early and late survival but that remains unproven. However, the success of the Norwood palliation for HLHS will also impact on these survival figures. (149) Survival for patients with an atriopulmonary Fontan may improve by conversion to a TCPC type Fontan. (150) The associated improvement in fluid mechanics and reduction in arrhythmia burden are likely to lead to survival improvements, but the operation requires careful consideration. (151) In carefully selected patients, the operation is associated with a low operative mortality. (151, 152) Role of transplantation
The difficulties of cardiac transplantation in patients with congenital heart disease has already been discussed in this journal (Bowater 2013) and its use in Fontan patients is well described. (153, 154) Early mortality is high (155) (156) (157) but later survival for those transplanted for impaired ventricular function is good. PLE prior to transplantation is associated with a poor long term outcome. (158, 159) With improving early survival from staged Fontan surgery, there will be an inevitable increase in adults with failing Fontan circulations in whom transplantation will be considered. The prospect of a mechanical Fontan support device has been raised and a number of designs have undergone mathematical modeling (160, 161) and animal studies. (162) (163) (164) Conflict of interest: none declared.
